Provided by Tiger Trade Technology Pte. Ltd.

Stoke Therapeutics, Inc.

28.44
-0.4900-1.69%
Volume:387.33K
Turnover:11.06M
Market Cap:1.84B
PE:-8.53
High:28.91
Open:28.85
Low:28.01
Close:28.93
52wk High:40.22
52wk Low:20.32
Shares:64.53M
Float Shares:49.01M
Volume Ratio:0.64
T/O Rate:0.79%
Dividend:- -
Dividend Rate:- -
EPS(TTM):-3.3325
EPS(LYR):-0.1163
ROE:-61.10%
ROA:-35.87%
PB:5.31
PE(LYR):-244.62

Loading ...

Apr 02, 2024

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Apr 02, 2024

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Mar 28, 2024

Major Issues Report

Form 8-K - Current report
Mar 28, 2024

[Supp]Public Prospectus

Form FWP - Filing under Securities Act Rules 163/433 of free writing prospectuses
Mar 28, 2024

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Mar 25, 2024

Annual Report

Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]
Mar 25, 2024

Major Issues Report

Form 8-K - Current report
Mar 25, 2024

Major Issues Report

Form 8-K - Current report
Mar 01, 2024

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Feb 26, 2024

Beneficial Ownership Change

Form SC 13G - Statement of acquisition of beneficial ownership by individuals
Feb 26, 2024

Beneficial Ownership Change

Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]
Feb 14, 2024

Beneficial Ownership Change

Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]
Feb 14, 2024

Beneficial Ownership Change

Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]
Feb 14, 2024

Beneficial Ownership Change

Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]
Feb 02, 2024

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Jan 08, 2024

Major Issues Report

Form 8-K - Current report
Jan 03, 2024

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Dec 15, 2023

Major Issues Report

Form 8-K - Current report
Dec 01, 2023

Major Issues Report

Form 8-K - Current report
Nov 18, 2023

Correspondence

Form CORRESP - Correspondence